课题基金 / 基金详情

DIDEOXYNUCLEOSIDES AS POTENTIAL ANTI-AIDS DRUGS

DIDEOXYNUCLEOSIDES AS POTENTIAL ANTI-AIDS DRUGS
双脱氧核苷作为潜在的抗艾滋病药物
批准号：
3838034
负责人：
V E MARQUEZ
金额：
$0.0万
依托单位：
DIVISION OF CANCER TREATMENT
依托单位国家：
美国
项目类别：
财政年份：
--
资助国家：
美国
项目状态：
未结题
起止时间：
至
来源：
https://reporter.nih.gov/project-details/3838034
关键词：
2'3' dideoxynucleoside adenosine deaminase antiAIDS agent antiviral agents chemical structure function conformation cyclic compound drug design /synthesis /production human immunodeficiency virus nuclear magnetic resonance spectroscopy prodrugs purine analog

项目摘要

项目成果

V E MARQUEZ的其他基金

相似基金

相关文献

中文摘要
翻译
一系列新的糖修饰的2',3'-二脱氧-2',3'-二氟核苷
英文摘要
A series of new sugar-modified 2',3'-dideoxy-2',3'-difluoro nucleosides were synthesized and the NMR solution conformations were determined. Specific forms of ring puckering were correlated with anti-HIV activity. A number of novel ring-expanded carbocyclic analogues of the fermentation product oxetanocin A were synthesized and evaluated for anti-HIV activity. As opposed to the dideoxyribose counterparts, these compounds were devoid of anti-HIV activity. Selected acid-stable 6-X-substituted-(2'-fluoro-2', 3'-dideoxy-beta-D-threo-pentofuranosyl)purines (X = F, Cl, Br, I, NHMe, NHEt, NHOH, NHOMe, NHOCH2 Ph) were prepared as anti-HIV adenosine deaminase-activated "pro-drugs". Their evaluation is in progress.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ENZYME INHIBITORS AS PROTENTIAL ANTICANCER AND ANTIVIRAL DRUGS
  • 批准号：
    5201243
  • 项目类别：
  • 资助金额：
    $0.0万
  • 财政年份：
    --
  • 负责人：
    V E MARQUEZ
  • 依托单位：
    DIVISION OF CANCER TREATMENT
DIDEOXYNUCLEOSIDES AS POTENTIAL ANTI-AIDS DRUGS
  • 批准号：
    5201241
  • 项目类别：
  • 资助金额：
    $0.0万
  • 财政年份：
    --
  • 负责人：
    V E MARQUEZ
  • 依托单位：
    DIVISION OF CANCER TREATMENT
CYCLOPENTENYL NUCLEOSIDE ISOSTERES AS POTENTIAL ANTITUMOR AND ANTIVIRAL AGENTS
  • 批准号：
    5201242
  • 项目类别：
  • 资助金额：
    $0.0万
  • 财政年份：
    --
  • 负责人：
    V E MARQUEZ
  • 依托单位：
    DIVISION OF CANCER TREATMENT
DIDEOXYNUCLEOSIDES AS POTENTIAL ANTI-AIDS DRUGS
海外基金